Palo Alto Investors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Hold |
|
|||||
|
2025
Q1 | $271K | Hold |
|
|||||
|
2024
Q4 | $261K | Hold |
|
|||||
|
2024
Q3 | $311K | Hold |
|
|||||
|
2024
Q2 | $411K | Hold |
|
|||||
|
2024
Q1 | $368K | Hold |
|
|||||
|
2023
Q4 | $368K | Hold |
|
|||||
|
2023
Q3 | $343K | Hold |
|
|||||
|
2023
Q2 | $254K | Hold |
|
|||||
|
2023
Q1 | $226K | Hold |
|
|||||
|
2022
Q4 | $217K | Hold |
|
|||||
|
2022
Q3 | $204K | Hold |
|
|||||
|
2022
Q2 | $201K | Hold |
|
|||||
|
2022
Q1 | $213K | Hold |
|
|||||
|
2021
Q4 | $233K | Hold |
|
|||||
|
2021
Q3 | $412K | Hold |
|
|||||
|
2021
Q2 | $374K | Hold |
|
|||||
|
2021
Q1 | $477K | Hold |
|
|||||
|
2020
Q4 | $441K | Hold |
|
|||||
|
2020
Q3 | $473K | Hold |
|
|||||
|
2020
Q2 | $640K | Hold |
|
|||||
|
2020
Q1 | $437K | Buy |
|